CHRNA7 and colitis: MLA (10 mg/kg, i.p.), a selective inhibitor of α7nAChR, abolished the inhibitory effects of ANI/NEO on weight loss, DAI, and colon length reduction in mice with DSS-induced colitis (Fig 8).